vs
HENNESSY ADVISORS INC（HNNA）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
RETRACTABLE TECHNOLOGIES INC的季度营收约是HENNESSY ADVISORS INC的1.1倍（$9.4M vs $8.3M），HENNESSY ADVISORS INC净利率更高（23.2% vs -24.9%，领先48.1%），RETRACTABLE TECHNOLOGIES INC同比增速更快（4.0% vs -14.3%），过去两年RETRACTABLE TECHNOLOGIES INC的营收复合增速更高（11.5% vs 9.5%）
总部位于美国的上市投资管理企业Hennessy Advisors Inc，提供共同基金、独立管理账户及专业投资咨询服务，服务覆盖个人投资者、金融中介与机构客户，核心业务包括适配不同风险偏好的定制化股票及固定收益投资策略。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
HNNA vs RVP — 直观对比
营收规模更大
RVP
是对方的1.1倍
$8.3M
营收增速更快
RVP
高出18.3%
-14.3%
净利率更高
HNNA
高出48.1%
-24.9%
两年增速更快
RVP
近两年复合增速
9.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.3M | $9.4M |
| 净利润 | $1.9M | $-2.3M |
| 毛利率 | — | -16.2% |
| 营业利润率 | 31.3% | -81.7% |
| 净利率 | 23.2% | -24.9% |
| 营收同比 | -14.3% | 4.0% |
| 净利润同比 | -31.9% | -162.3% |
| 每股收益（稀释后） | $0.24 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HNNARVP
| Q4 25 | $8.3M | $9.4M | ||
| Q3 25 | $8.5M | $10.1M | ||
| Q2 25 | $8.1M | $10.4M | ||
| Q1 25 | $9.3M | $8.3M | ||
| Q4 24 | $9.7M | $9.1M | ||
| Q3 24 | $8.8M | $10.3M | ||
| Q2 24 | $7.8M | $6.0M | ||
| Q1 24 | $6.9M | $7.6M |
净利润HNNARVP
| Q4 25 | $1.9M | $-2.3M | ||
| Q3 25 | $2.4M | $371.0K | ||
| Q2 25 | $2.1M | $-87.5K | ||
| Q1 25 | $2.6M | $-10.5M | ||
| Q4 24 | $2.8M | $3.8M | ||
| Q3 24 | $2.3M | $-1.9M | ||
| Q2 24 | $2.0M | $-14.2M | ||
| Q1 24 | $1.5M | $429.4K |
毛利率HNNARVP
| Q4 25 | — | -16.2% | ||
| Q3 25 | — | 16.7% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | -0.0% | ||
| Q4 24 | — | -27.5% | ||
| Q3 24 | — | -0.1% | ||
| Q2 24 | — | -7.0% | ||
| Q1 24 | — | 25.0% |
营业利润率HNNARVP
| Q4 25 | 31.3% | -81.7% | ||
| Q3 25 | 35.5% | -36.2% | ||
| Q2 25 | 35.4% | -49.1% | ||
| Q1 25 | 37.2% | -56.4% | ||
| Q4 24 | 39.5% | -79.6% | ||
| Q3 24 | 33.5% | -49.6% | ||
| Q2 24 | 33.2% | -95.6% | ||
| Q1 24 | 27.7% | -39.3% |
净利率HNNARVP
| Q4 25 | 23.2% | -24.9% | ||
| Q3 25 | 28.5% | 3.7% | ||
| Q2 25 | 26.3% | -0.8% | ||
| Q1 25 | 27.8% | -126.6% | ||
| Q4 24 | 29.2% | 41.6% | ||
| Q3 24 | 26.5% | -18.6% | ||
| Q2 24 | 26.1% | -234.9% | ||
| Q1 24 | 22.2% | 5.7% |
每股收益（稀释后）HNNARVP
| Q4 25 | $0.24 | $-0.09 | ||
| Q3 25 | $0.32 | $0.01 | ||
| Q2 25 | $0.26 | $0.00 | ||
| Q1 25 | $0.33 | $-0.35 | ||
| Q4 24 | $0.36 | $0.14 | ||
| Q3 24 | $0.30 | $-0.07 | ||
| Q2 24 | $0.26 | $-0.48 | ||
| Q1 24 | $0.20 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.0M | $2.6M |
| 总债务越低越好 | — | $895.6K |
| 股东权益账面价值 | $98.9M | $74.4M |
| 总资产 | $159.6M | $142.6M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资HNNARVP
| Q4 25 | $72.0M | $2.6M | ||
| Q3 25 | $72.4M | $3.4M | ||
| Q2 25 | $70.3M | $3.0M | ||
| Q1 25 | $67.6M | $3.4M | ||
| Q4 24 | $65.0M | $4.2M | ||
| Q3 24 | $63.9M | $3.9M | ||
| Q2 24 | $62.0M | $6.9M | ||
| Q1 24 | $59.6M | $10.0M |
总债务HNNARVP
| Q4 25 | — | $895.6K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HNNARVP
| Q4 25 | $98.9M | $74.4M | ||
| Q3 25 | $97.7M | $76.8M | ||
| Q2 25 | $96.5M | $76.5M | ||
| Q1 25 | $95.2M | $76.6M | ||
| Q4 24 | $93.4M | $87.2M | ||
| Q3 24 | $91.3M | $83.5M | ||
| Q2 24 | $90.2M | $85.4M | ||
| Q1 24 | $88.9M | $99.7M |
总资产HNNARVP
| Q4 25 | $159.6M | $142.6M | ||
| Q3 25 | $160.5M | $146.4M | ||
| Q2 25 | $158.0M | $147.1M | ||
| Q1 25 | $155.5M | $149.3M | ||
| Q4 24 | $153.3M | $160.7M | ||
| Q3 24 | $152.1M | $157.8M | ||
| Q2 24 | $149.5M | $160.7M | ||
| Q1 24 | $147.3M | $176.0M |
负债/权益比HNNARVP
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $661.0K | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $601.0K | — |
| 自由现金流率自由现金流/营收 | 7.2% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 0.34× | — |
| 过去12个月自由现金流最近4个季度 | $21.6M | — |
8季度趋势，按日历期对齐
经营现金流HNNARVP
| Q4 25 | $661.0K | $-596.5K | ||
| Q3 25 | $13.8M | $-1.3M | ||
| Q2 25 | $4.0M | $-3.7M | ||
| Q1 25 | $3.7M | $-1.5M | ||
| Q4 24 | $2.2M | $-1.1M | ||
| Q3 24 | $9.3M | $-5.7M | ||
| Q2 24 | $3.6M | $-2.7M | ||
| Q1 24 | $1.9M | $-2.0M |
自由现金流HNNARVP
| Q4 25 | $601.0K | — | ||
| Q3 25 | $13.4M | $-1.3M | ||
| Q2 25 | $3.9M | $-4.1M | ||
| Q1 25 | $3.7M | $-1.6M | ||
| Q4 24 | $2.1M | $-1.4M | ||
| Q3 24 | $9.0M | $-6.5M | ||
| Q2 24 | $3.5M | $-2.8M | ||
| Q1 24 | $1.8M | $-2.2M |
自由现金流率HNNARVP
| Q4 25 | 7.2% | — | ||
| Q3 25 | 157.1% | -13.4% | ||
| Q2 25 | 49.0% | -38.9% | ||
| Q1 25 | 39.5% | -18.8% | ||
| Q4 24 | 21.8% | -15.5% | ||
| Q3 24 | 102.1% | -63.0% | ||
| Q2 24 | 44.4% | -46.8% | ||
| Q1 24 | 26.0% | -29.6% |
资本支出强度HNNARVP
| Q4 25 | 0.7% | — | ||
| Q3 25 | 5.2% | 0.9% | ||
| Q2 25 | 0.8% | 3.2% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 1.2% | 3.3% | ||
| Q3 24 | 3.6% | 7.7% | ||
| Q2 24 | 1.2% | 2.0% | ||
| Q1 24 | 1.0% | 3.0% |
现金转化率HNNARVP
| Q4 25 | 0.34× | — | ||
| Q3 25 | 5.69× | -3.39× | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 0.79× | -0.29× | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | 1.22× | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HNNA
| Investment Advice | $7.8M | 93% |
| Other | $559.0K | 7% |
RVP
暂无分部数据
